Physician Attitude And Behavior Associated With Direct And Otc Medications

The utilization of prescription drugs has increased across all age groups in the US, with 50% of Americans taking at least one prescription drug (Rice & Unruh, 2016). This can be attributed to physician-induced demand, substitution of pharmaceuticals for other medical regimens, commercialization of the products, increase in the aging population and drug insurance coverage, and also the increase in chronic conditions. Lathan discusses the startling fact that the rate increase of prescription drugs purchased was considerably higher in contrast to the US population growth - 71% and 9% respectively (Rice & Unruh, 2016, p. 264).

Ads for pharmaceutical drugs are everywhere. They are in magazines, on television and radio, on billboards, and on the little bags that you get from the pharmacist. These days it is difficult to get away from all the drug advertising. All these ads are for products that require a doctor's prescription. The goal of advertising is to increase profits. By advertising so heavily for drugs that the majority of the population does not need, pharmaceutical companies attempt to create as large a consumer base as they can. In advertising directly to the consumer, the drug companies accomplish two objectives. First, they get information directly to the consumer. Second, they promote the product and

Despite this, the industry did not alter its ways, maintaining that its ad campaigns were "educational," and that people were able to make their own decisions about what they purchased (Payer 66). However, it is evident that the advertisements produced by the pharmaceutical industry are designed for the very purpose of making it difficult for people to make these decisions independently. This marketing produces a large number of often deceptive, misleading tactics which have a large influence on both consumers and medical practitioners. The chief beneficiaries of this marketing are not the consumers but the pharmaceutical companies themselves.

There are proponents of DTC prescription drug ads. They argue that “the ads inform patients about diseases and possible treatments, encourage people to seek medical advice, help remove stigma associated with medical conditions, and provide needed sales revenue to fund costly research and development (R&D) of new drugs (Drug Ads ProCon.org).” On the flip side opponents argue “that DTC drug ads misinform patients, promote drugs before long-term safety-profiles can be known, medicalize and stigmatize normal conditions and bodily functions like wrinkles and low testosterone, waste valuable medical appointment time, and have led to our society’s overuse of prescription drugs (Drug Ads ProCon.org).”

In 2015, the pharmaceutical industry spent over 27 billion dollars on advertising. The two greatest components of this effort were promotional advertising and free medication sampling, which the pharmaceuticals invested 15.5 and 5.7 billion dollars respectively (“Persuading the Prescribers”). Promotional advertising involves direct contact with health professionals, the most common being extravagant lunch conferences held for physicians and their staff. On the other hand, sampling involves distributing free sample of medications to physicians, who then have a choice of providing these samples to patients. As a result of these methods, the industry has seen revenue around $400 billion with 90% of physicians having a relationship with a drug company (Campbell 2007). Moreover, the prices of prescriptions continue to rise; a copay of a generic drug is $11.72, preferred brand drug is $36.37 and a specialty drug is $58.37 (Coleman and Geneson 2014). Although the profits are immense in the numbers demonstrated above, it is no surprise when pharmaceutical drug companies elevate their prices even more. For instance, recently Turing Pharmaceuticals raised the price of their medication Daraprim from $13.50 to $750. Keep in mind, this medication is used for threatening parasitic infections, aids, and cancer with alternative options currently found to be inefficient (Pollack 2015). Another example of this practice involves cycloserine, a drug used to

Commercialized on TV as the only solution to our numerous problems, Big Pharma preys on people who struggle through life. Although seemingly meant to heal, pharmaceutical drugs have destroyed countless American lives instead because gullible patients rush to their doctor demanding prescriptions. Want to lose weight? Give me a pill. Want more intense sexual encounters? I need a pill. Want to grow longer, shinier hair? Hey, I’ll just pop a pill. Although some medical conditions do require medication, not every case of discomfort should be treated with highly addictive prescription meds nor should those drugs be trafficked via commercials that target a hypochondriacal nation of couch potatoes too lazy to put forth the time and effort to prevent disease. Instead, far too many Americans simply find a quick fix at their local pharmacy. These prescriptions lead to addiction and in the end death. Therefore, if I could take away any one invention from mankind it would be the crass commercialization of pharmaceuticals.

Annually, the US spends $300 billion dollars on pharmaceutical drugs. This is due to the over-diagnosing of certain conditions. Everyday, Americans are exposed to an enormous amount of advertisements for medications of all kinds. For example, 1 in 10 Americans are taking

We in America tend to take medications for almost any problem we have, from headaches to gastrointestinal pain, to more serious chronic disorders such as depression and attention deficit disorder. While many of the uses of such medications may be necessary and legitimate, many are not, and due to this fact, many people become dependent on medications, mentally, and or physically. This problem is not simply the fault of the individual; in fact, the blame can also be placed upon the medical community, and the pharmaceutical companies who produce the drugs. How often can one turn on the television to see advertisements for Claritin, Aspirin, Pepto-Bismol, or even Zoloft or Ritalin? The pharmaceutical industry is motivated by monetary

The rise in costs of prescription medicines affects all sectors of the health care industry, including private insurers, public programs, and patients. Spending on prescription drugs continues to be an important health care concern, particularly in light of rising pharmaceutical costs, the aging population, and increased use of costly specialty drugs. In recent history, increases in prescription drug costs have outpaced other categories of health care spending, rising rapidly throughout the latter half of the 1990s and early 2000s. (Kaiseredu.org, 2012).

So studying the presence and magnitude of this habit persistence in physician drug choice is very important from a public policy point of view also. If the persistence in drug choice of the physicians increases, it can prevent the adoption of these low-cost generic drugs, and it might put pressure on the overall healthcare costs. Usually generic drugs are known for a cheaper price and easily available in the market, and they can reduce the healthcare costs significantly. In addition, the presence of significant drug persistence in physician drug choice could act as a barrier to the adoption of innovations and of new medical technologies coming up in the market. So understanding of the prescribing behavior or the prescribing trends of physicians

There are many direct to consumer advertising for prescription drugs. On television, magazines, radio etc, you see the most recent advertisements for prescription drugs. After some people see the advertisements they soon rush over to their doctor and their illness and life would be perfectly pain and stress free. Making the public conscious of options for treatment is not a bad thing. But these false advertisements are misleading consumers onto unnecessary treatment.

A great example of direct-to-consumer advertising having a positive impact is its role in cholesterol treatment and knowledge. Years ago, the medical community wasn’t very concerned about the effects cholesterol may have on heart disease (Ford, 2010). Now we know that prolonged high levels of cholesterol can lead to atherosclerosis (Ford, 2010). A large part of this knowledge was brought to light by marketing done by pharmaceutical companies (Wolinsky, 2005). As a result, hypercholesterolemia is now recognized as a serious health problem and is one of the most popular diagnoses treated by a pharmaceutical (Wolinsky, 2005).

The Impact of Pseudoscience on Consumers Pseudoscience is known by many as false science. Many consumers are convinced by companies that sells these products provide instant cures that lead to a healthier lifestyle. These products are scientific theories that have little evidence to back up their scientific claims. The Internet, health food stores, magazines, and commercials are just a few ways that companies can target potential consumers to sell their products. Medical information searched by consumers via the Internet has become the largest source of information worldwide. Consumers search the Internet for weight loss strategies, treatments for autism, anti-aging creams, male enhancement, and prevention of cancer and heart

Prescription drug advertisements have a negative impact on Americans by causing them to become hypochondriacs in a certain way. A hypochondriac is someone who believes and becomes obsessed with the idea that they have a serious condition that was and is undiagnosed. This problem continues to have a negative affect because it can lead to unnecessarily prescribing. Patients are going into their doctors and they are requesting to be put on these drugs because of the great affects that they have heard that they do for them. In the article, Direct-to-Consumer Pharmaceutical Advertising, the author states that in a study done over this and the results were that, when these request were made at about 40 percent of doctor visits and during this time more

The implications of these two differences in terms of positioning strategies are vast. The inability to utilize DTC advertising prevented the U.K. from successfully pursuing alternative positioning strategies, such patient-based segmentation, due to concerns about the physician’s ability to identify such segments and further confusing the prescribing process. Moreover, in a socialized health care system where patients are entitled to free medical care, patients can seek treatment easier and can be less involved in the prescribing process than in an insurance-based system where there is more monetary involvement. Although this strategy might communicate a clear message about the drug’s superiority, it would devalue the brand name built for Imitrex, drastically impacting its potential profitability as well as the ability to continue to recuperate the high investments already sunk into the R&D and marketing of Imitrex.